In this episode, Joseph and Paula explore ibogaine, an increasingly discussed and controversial substance in addiction treatment. They break down what ibogaine is, what it claims to do, and the current realities surrounding its use, including risks, legal status, and ethical considerations. With a focus on both curiosity and caution, this conversation invites counselors and listeners alike to think critically about emerging treatments and the evolving landscape of recovery. 

Questions? If you have questions, you would like Joseph and Paula to address during an upcoming episode of Questions for Counselors, feel free to reach out through the website at www.lifelivedbetter.net or email them directly at [email protected]    

You can find information about this and other episodes on the website: www.lifelivedbetter.net.    

Just a reminder - Anything shared during this and all other episodes is based on personal experiences and opinions. It is not to be viewed as professional counseling or advice - it is solely our opinion. Information shared does not represent our employers or profession.  

We would love for you to rate our show and tell others about us.  

And remember, Knowledge leads to a Life Lived Better.   

Resources used to create this episode: 

ANR Clinic - Advanced Opioid Dependency Treatment Centers 

Frontiers | Ibogaine Detoxification Transitions Opioid and Cocaine Abusers 

Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes 

Ibogaine - Partnership to End Addiction 

Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets 

Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study - PMC 

Study Details | NCT05029401 | A Study of Oral Ibogaine in Opioid Withdrawal | ClinicalTrials.gov 

Trump takes page out of Texas lawmakers' book, signs executive order on ibogaine 

UTHealth Houston, in collaboration with UTMB Health, awarded $50 million by the state of Texas to lead ibogaine clinical trials - UTHealth Houston